Abstract
In the past few years, a myriad of technologies have been developed for percutaneous repair of the mitral valve for patients with severe mitral regurgitation (MR) and at high risk for traditional open-heart mitral valve surgery. Among them, MitraClip has emerged as the only clinically safe and effective method for percutaneous mitral valve repair. This device mimics the surgical edge-to-edge mitral valve repair initially described by Dr. Alfieri. In this article, we review the current clinical evidence on the use of the MitraClip—from the randomized control trial EVEREST II to the information derived from expert high-volume centers.
Zusammenfassung
In den letzten Jahren wurden zahlreiche Techniken für die perkutane Rekonstruktion der Mitralklappe bei Patienten mit schwerer Mitralklappeninsuffizienz und hohem Risiko für eine herkömmliche Mitralklappenoperation am offenen Herzen entwickelt. Der MitraClip hat sich daraus als die einzige klinisch sichere und wirksame Methode für die perkutane Mitralklappenrekonstruktion herausgestellt. Mit diesem Verfahren wird die erstmals von Alfieri beschriebene Edge-to-Edge-Mitralklappenoperation imitiert. Im vorliegenden Beitrag wird die aktuelle klinische Erfahrung mit dem MitraClip dargestellt – von der randomisierten kontrollierten Studie EVEREST II bis zu Informationen von erfahrenen Zentren mit hohem Durchsatz.
Similar content being viewed by others
References
Nkomo VT, Gardin JM, Skelton TN et al (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011
Bursi F, Enriquez-Sarano M, Nkomo VT et al (2005) Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111:295–301
Robbins JD, Maniar PB, Cotts W et al (2003) Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 91:360–362
Trichon BH, Felker GM, Shaw LK et al (2003) Relation of frequency and severity of mitral regurgitation to survival among. Am J Cardiol 91(5):538–543
Carpentier A (1983) Cardiac valve surgery–the “French correction”. J Thorac Cardiovasc Surg 86(3):323–337
Adams DH, Rosenhek R, Falk V (2010) Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J 31:1958–1966
Barlow JB, Pocock WA (1963) The significance of late systolic murmurs and mid-late systolic clicks. Md State Med J 12:76–77
Enriquez-Sarano M, Schaff HV, Orszulak TA et al (1995) Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 91(4):1022–1028
Seeburger J, Falk V, Borger MA et al (2009) Chordae replacement versus resection for repair of isolated posterior mitral leaflet prolapse: a egalite. Ann Thorac Surg 87:1715–1720
Gillinov AM, Cosgrove DM, Blackstone EH et al (1998) Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 116:734–743
Maisano F, Torracca L, Oppizzi M et al (1998) The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 13:240–245 (discussion 5–6)
Maisano F, Vigano G, Blasio A et al (2006) Surgical isolated edge-to-edge mitral valve repair without annuloplasty: clinical proof of the principle for an endovascular approach. EuroIntervention 2(2):181–186
Wu AH, Aaronson KD, Bolling SF et al (2005) Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45:381–387
Hung J, Papakostas L, Tahta SA et al (2004) Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation 110:II85–II90
McGee EC, Gillinov AM, Blackstone EH et al (2004) Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128:916–924
Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496
Mirabel M, Iung B, Baron G et al (2007) What are the characteristics of patients with severe, symptomatic, mitral. Eur Heart J 28(11):1358–1365
Borger MA, Alam A, Murphy PM et al (2006) Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann Thorac Surg 81(3):1153–1161
Jamieson WR, Edwards FH, Schwartz M et al (1999) Risk stratification for cardiac valve replacement. National Cardiac Surgery. Ann Thorac Surg 67(4):943–951
Alfieri O, Maisano F, De Bonis M et al (2001) The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 122:674–681
Silvestry FE, Rodriguez LL, Herrmann HC et al (2007) Echocardiographic guidance and assessment of percutaneous repair for mitral. J Am Soc Echocardiogr 20(10):1131–1140
Feldman T, Wasserman HS, Herrmann HC et al (2005) Percutaneous mitral valve repair using the edge-to-edge technique: six-month. J Am Coll Cardiol 46(11):2134–2140
Bonow RO, Carabello B, Leon AC de Jr et al (1998) Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 98(18):1949–1984
Feldman T, Kar S, Rinaldi M et al (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm. J Am Coll Cardiol 54(8):686–694
Feldman T, Foster E, Glower DD et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364(15):1395–1406
Whitlow PL, Feldman T, Pedersen WR et al (2012) Acute and 12-month results with catheter-based mitral valve leaflet repair: the. J Am Coll Cardiol 59(2):130–139
Franzen O, Baldus S, Rudolph V et al (2010) Acute outcomes of MitraClip therapy for mitral regurgitation in. Eur Heart J 31(11):1373–1381
Franzen O, Heyden J van der, Baldus S et al (2011) MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 13(5):569–576
Rudolph V, Knap M, Franzen O et al (2011) Echocardiographic and clinical outcomes of MitraClip therapy in patients not. J Am Coll Cardiol 58(21):2190–2195
Auricchio A, Schillinger W, Meyer S et al (2011) Correction of mitral regurgitation in nonresponders to cardiac resynchronization. J Am Coll Cardiol 58(21):2183–2189
Grasso C, Capodanno D, Scandura S et al (2013) One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). Am J Cardiol 111(10):1482–1487
Surder D, Pedrazzini G, Gaemperli O et al (2013) Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart
Paranskaya L, D’Ancona G, Bozdag-Turan I et al (2013) Residual mitral valve regurgitation after percutaneous mitral valve repair with the mitraclip® system is a risk factor for adverse one-year outcome. Catheter Cardiovasc Interv 81(4):609–617
Paranskaya L, D’Ancona G, Bozdag-Turan I et al (2012) Percutaneous mitral valve repair with the mitraclip(®) system. Catheter Cardiovasc Interv
Ussia GP, Cammalleri V, Sarkar K et al (2012) Quality of life following percutaneous mitral valve repair with the MitraClip System. Int J Cardiol 155:194–200
Chan PH, Di Mario C, Franzen O (2012) Dissociation between anatomical and functional results after MitraClip implantation. Int J Cardiol 155:175–176
Baldus S, Schillinger W, Franzen O et al (2012) MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail 14:1050–1055
Schillinger W, Hunlich M, Baldus S et al (2013) Acute outcomes after MitraClip® therapy in highly aged patients: results from. EuroIntervention 9(1):84–90
Tamburino C, Ussia GP, Maisano F et al (2010) Percutaneous mitral valve repair with the MitraClip system: acute results from a. Eur Heart J 31(11):1382–1389
Divchev D, Kische S, Paranskaya L et al (2012) In-hospital outcome of patients with severe mitral valve regurgitation classified as inoperable and treated with the MitraClip® device. J Interv Cardiol 25(2):180–189
Chan PH, She HL, Alegria-Barrero E et al (2012) Real-world experience of MitraClip for treatment of severe mitral regurgitation. Circ J 76:2488–2493
Schillinger W, Athanasiou T, Weicken N et al (2011) Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients. Eur J Heart Fail 13:1331–1339
Siegel RJ, Biner S, Rafique AM et al (2011) The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol 57:1658–1665
Biner S, Siegel RJ, Feldman T et al (2012) Acute effect of percutaneous MitraClip therapy in patients with haemodynamic decompensation. Eur J Heart Fail 14:939–945
Gaemperli O, Biaggi P, Gugelmann R et al (2013) Real-time left ventricular pressure-volume loops during percutaneous mitral valve repair with the Mitraclip system. Circulation 127:1018–1027
Rudolph V, Lubos E, Schluter M et al (2013) Aetiology of mitral regurgitation differentially affects 2-year adverse outcomes after MitraClip therapy in high-risk patients. Eur J Heart Fail
Taramasso M, Denti P, Buzzatti N et al (2012) Mitraclip therapy and surgical mitral repair in patients with moderate to severe. Eur J Cardiothorac Surg 42(6):920–926
Wu A, Arronson K, Buzzatti N et al (2005) Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular dysfunction. J Am Coll Cardiol 45:381–387
Conflict of interest
On behalf of all authors, the corresponding author states that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Estevez-Loureiro, R., Franzen, O. Percutaneous edge-to-edge mitral valve repair. Herz 38, 448–452 (2013). https://doi.org/10.1007/s00059-013-3868-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-013-3868-1